Less Ads, More Data, More Tools Register for FREE

Pin to quick picksASOS Regulatory News (ASC)

Share Price Information for ASOS (ASC)

Share Price is delayed by 15 minutes
Get Live Data
277.00    4.50 (1.65%)
Bid:
276.00
Ask:
279.00
Spread: 3.00 (1.087%)
Market Cap: £331.43m
ASC Live PriceLast checked at - London Stock Exchange

Intraday ASOS Share Chart

Share Plan

19 Jan 2010 17:56

RNS Number : 8122F
ASOS PLC
19 January 2010
 



19 January 2010

ASOS plc ('ASOS' or the 'Company')

Save As You Earn Scheme and Director's Shareholding

Under the ASOS plc HMRC Approved Save As You Earn Option Plan (the "SAYE Plan"), the Company has been notified that the trustee of the SAYE Plan has purchased 75,924 ordinary shares of 3.5 pence each in the Company ("Ordinary Shares") in the market (at a price of 439.98 pence per share). 

Following this transaction, the trustee holds a total of 1,437,305 Ordinary Shares, representing approximately 1.9% of the Company's issued Ordinary Share capital.

The following director has, under the terms of the SAYE Plan, acquired the option to acquire shares at 336 pence per share via the SAYE Plan and is accordingly treated as having the following interest in such Ordinary Shares:

Name Number of Shares

Nick Beighton, Finance Director  2,700  

For further information: 

ASOS plc 

Nick Robertson, Chief Executive   Tel: 0207 756 1000 

Nick Beighton, Finance Director 

Website: www.asos.com

College Hill

Matthew Smallwood / Justine Warren / Jamie Ramsay Tel: 020 7457 2020 

J.PMorgan Cazenove 

Luke Bordewich / Gina Gibson Tel: 020 7588 2828

Numis Securities

Alex Ham  Tel: 020 7260 1000

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSGGUCAGUPUGMB
Date   Source Headline
2nd Dec 20227:06 amRNSExecutive Change
30th Nov 20224:18 pmRNSDirector/PDMR Shareholding
10th Nov 20221:03 pmRNSNotice of AGM and Annual Report & Accounts
1st Nov 202212:12 pmRNSDirector/PDMR Shareholding
1st Nov 20229:37 amRNSTotal Voting Rights
27th Oct 202211:27 amRNSAdditional Listing
24th Oct 20229:52 amRNSHolding(s) in Company
19th Oct 202212:36 pmRNSDirector/PDMR Shareholding
19th Oct 20227:00 amRNSFinal Results
17th Oct 20227:00 amRNSResponse to media reporting
11th Oct 20229:27 amRNSHolding(s) in Company
7th Oct 20221:15 pmRNSHolding(s) in Company
7th Oct 20229:26 amRNSHolding(s) in Company
3rd Oct 20223:09 pmRNSHolding(s) in Company
3rd Oct 202210:44 amRNSTotal Voting Rights
23rd Sep 202210:38 amRNSHolding(s) in Company
16th Sep 20229:00 amRNSDirectorate Change
9th Sep 20227:00 amRNSTrading Statement
1st Sep 202211:24 amRNSTotal Voting Rights
31st Aug 20229:21 amRNSHolding(s) in Company
30th Aug 20223:51 pmRNSHolding(s) in Company
26th Aug 20221:11 pmRNSHolding(s) in Company
25th Aug 20221:31 pmRNSHolding(s) in Company
25th Aug 202211:23 amRNSHolding(s) in Company
17th Aug 20227:00 amRNSDirectorate Change
15th Aug 202210:21 amRNSHolding(s) in Company
15th Aug 202210:12 amRNSHolding(s) in Company
1st Aug 202210:59 amRNSTotal Voting Rights
29th Jul 20227:29 amRNSResponse to CMA announcement
1st Jul 20229:22 amRNSTotal Voting Rights
24th Jun 20229:55 amRNSHolding(s) in Company
24th Jun 20229:52 amRNSDirector/PDMR Shareholding
22nd Jun 20229:14 amRNSHolding(s) in Company
20th Jun 202210:49 amRNSDirector/PDMR Shareholding
17th Jun 202211:10 amRNSDirector/PDMR Shareholding
17th Jun 20229:35 amRNSHolding(s) in Company
16th Jun 20227:01 amRNSTrading Statement
16th Jun 20227:00 amRNSASOS announces Board changes
1st Jun 202210:54 amRNSTotal Voting Rights
19th May 20228:59 amRNSDirector Declaration
3rd May 202210:22 amRNSTotal Voting Rights
3rd May 202210:10 amRNSHolding(s) in Company
29th Apr 20224:07 pmRNSHolding(s) in Company
22nd Apr 202210:08 amRNSHolding(s) in Company
19th Apr 202210:46 amRNSHolding(s) in Company
12th Apr 20227:00 amRNSInterim Results
1st Apr 20229:38 amRNSTotal Voting Rights
14th Mar 202212:19 pmRNSDirector Declaration
2nd Mar 20226:24 pmRNSUpdate on impact of Russian invasion of Ukraine
1st Mar 20222:54 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.